While #monalessa3 allowed men with #metastaticbreastcancer to enroll, no men did. One reason why was stated to be that there are so few men, but when 400+ men/yr die, I argue that lack of incidence isn’t the problem but rather lack of education about trials. 1/2. #AAADV19